Abstract
Changes in body composition in cancer patients are associated with greater toxicity to cancer treatment and may affect its therapeutic response. Studies show that low muscle radiodensity (myosteatosis) in patients with colon cancer is correlated with increased toxicity to adjuvant treatment. Adipose tissue radiodensity is also associated with higher mortality rates in cancer patients and …